APP and Alzheimer disease: By enhancing the non-amyloidogenic processing of amyloid precursor protein (APP) via increased α-secretase activity, SIRT1 reduces the production and accumulation of amyloid-β peptides, which are key pathological factors in Alzheimer’s disease [10].